Equities researchers at William Blair decreased their FY2025 earnings per share estimates for shares of Cheesecake Factory in ...
William Blair downgrades Booz Allen, CACI International, Leidos, Parsons and General Dynamics on the heightened risk of ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Hosted on MSN2d
William Blair Downgrades CACI International (CACI)Fintel reports that on February 21, 2025, William Blair downgraded their outlook for CACI International (NYSE:CACI) from ...
Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...
William Blair downgraded Booz Allen (BAH) to Market Perform from Outperform.Discover the Best Stocks and Maximize Your Portfolio: See what ...
William Blair analyst Arjun Bhatia maintained a Buy rating on Radcom (RDCM – Research Report) today. The company’s shares opened today at ...
Pediatrix Medical reported Q4 revenue of $502.36 million, surpassing estimates, with adjusted EPS of $0.51. The company ...
Repligen Corp (NASDAQ:RGEN) released its fourth-quarter adjusted EPS of 44 cents on Tuesday, down from 48 cents a year ago ...
周五，William Blair分析师对AAON Inc (NASDAQ: AAON )保持看多态度，维持"优于大市"评级，但下调了2025年上半年的盈利预期。此次调整反映了德克萨斯州朗维尤和田纳西州孟菲斯工厂的一次性启动成本。分析师将2025年每股收益（EPS）预期从此前的$3.20下调至$3.04，而市场共识预期为$2.94。根据InvestingPro数据显示，六位分析师最近下调了其盈利预期 ...
Research analysts at William Blair reduced their Q1 2025 earnings per share estimates for Dynavax Technologies in a report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback